## **Core Concept**
High plasma protein binding to serum albumin is a significant pharmacokinetic property of certain drugs. Serum albumin is the most abundant protein in human plasma, and it plays a crucial role in binding various substances, including drugs, thereby affecting their distribution, efficacy, and duration of action. Drugs that are highly bound to plasma proteins tend to have a smaller volume of distribution and may have reduced clearance.

## **Why the Correct Answer is Right**
The correct answer, . Warfarin is known for its high binding affinity to serum albumin, with approximately 97-99% of the drug being bound to plasma proteins, primarily albumin. This high plasma protein binding affects warfarin's pharmacokinetics and pharmacodynamics, influencing its anticoagulant effect and interaction with other highly bound drugs.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While some NSAIDs are highly bound to plasma proteins, specific details about their binding affinity can vary, and not all are as highly bound as warfarin.
- **Option B:** Similar to NSAIDs, certain antidiabetic drugs may exhibit plasma protein binding, but the extent can vary widely among different drugs in this class.
- **Option C:** Some antihypertensive drugs may have significant plasma protein binding, but again, the specifics can vary, and they are not typically highlighted for high albumin binding to the extent of warfarin.

## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is that drugs with high plasma protein binding can displace each other from albumin binding sites, potentially leading to increased free (active) concentrations of one or both drugs when co-administered. This can increase the risk of adverse effects or toxicity. Warfarin, being highly bound to albumin, is a classic example where such interactions can be clinically significant.

## **Correct Answer: D. Warfarin.**